Get started
Author

Jeremy L. Davis

Observed names: Davis, Jeremy, J L Davis, J. Davis, Jeremy Davis, Jeremy L Davis, Jeremy Lee Davis, Jeremy, Davis
Observed institutions: University of Maryland, Baltimore, National Institutes of Health, Memorial Sloan Kettering Cancer Center, University of Maryland Medical System, University of Tennessee Health Science Center, University of Georgia, University of Utah, Government of the United States of America, Ghent University, University of Florida, National Institute of Diabetes and Digestive and Kidney Diseases, Dartford And Gravesham NHS Trust, Arog Pharmaceuticals (United States), National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Cancer Institute, Center for Cancer Research, Erasmus MC Cancer Institute, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Daniel den Hoed Kliniek, University of Arkansas for Medical Sciences
ORCID: 0000-0002-6334-6936
Observed ORCID: 0000-0002-6334-6936
OpenAlex ID: A5066867006
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
2009 · Laura A. Johnson, Richard A. Morgan, et al. · Blood · 1,418
PDF
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
2010 · Maria R Parkhurst, James C Yang, et al. · Molecular Therapy · 1,021
Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
2019 · Lichun Ma, Maria O. Hernandez, et al. · Cancer Cell · 844
PDF
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
2016 · Austin G. Duffy, Susanna V. Ulahannan, et al. · Journal of Hepatology · 819
PDF
Hereditary diffuse gastric cancer: updated clinical practice guidelines
2020 · Vanessa R Blair, Maybelle McLeod, et al. · The Lancet Oncology · 492
PDF
Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
2021 · Lichun Ma, Limin Wang, et al. · Journal of Hepatology · 373
PDF
Single‐cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
2018 · Hongping Zheng, Yotsawat Pomyen, et al. · Hepatology · 349
PDF
Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
2012 · Richard A. Morgan, Laura A. Johnson, et al. · Human Gene Therapy · 311
IBEX: A versatile multiplex optical imaging approach for deep phenotyping and spatial analysis of cells in complex tissues
2020 · Andrea J. Radtke, Evelyn Kandov, et al. · Proceedings of the National Academy of Sciences · 203
PDF
IBEX: an iterative immunolabeling and chemical bleaching method for high-content imaging of diverse tissues
2022 · Andrea J. Radtke, Colin J. Chu, et al. · Nature Protocols · 136
Development of Human Anti-Murine T-Cell Receptor Antibodies in Both Responding and Nonresponding Patients Enrolled in TCR Gene Therapy Trials
2010 · Jeremy L. Davis, Marc R. Theoret, et al. · Clinical Cancer Research · 128
Postgastrectomy Syndromes and Nutritional Considerations Following Gastric Surgery
2017 · Jeremy L. Davis, R. Taylor Ripley · Surgical Clinics of North America · 123
Patterns and Predictors of Weight Loss After Gastrectomy for Cancer
2016 · Jeremy L. Davis, Luke V. Selby, et al. · Annals of Surgical Oncology · 105
Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
2020 · Changqing Xie, Austin G. Duffy, et al. · Clinical Cancer Research · 101
Computerized quality-of-life screening in an oncology clinic.
1997 · P A Taenzer, M Speca, et al. · PubMed · 100
The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
2024 · Vasileios Oikonomou, Grace Smith, et al. · New England Journal of Medicine · 89
PDF
Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes
2013 · Daniel Abate-Daga, Ken-ichi Hanada, et al. · Blood · 88
Hereditary Diffuse Gastric Cancer Syndrome and the Role of CDH1
2021 · Lauren A. Gamble, Theo Heller, et al. · JAMA Surgery · 82
Germline CDH1 Variants and Lifetime Cancer Risk
2024 · Carrie E. Ryan, Grace-Ann Fasaye, et al. · JAMA · 75
Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients
2024 · Andrea J. Radtke, Ekaterina Postovalova, et al. · Cancer Cell · 71
Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study
2023 · Bilal Asif, Amber Leila Sarvestani, et al. · The Lancet Oncology · 67
PDF
Liver Resection and Ablation for Metastatic Adrenocortical Carcinoma
2011 · R. Taylor Ripley, Clinton D. Kemp, et al. · Annals of Surgical Oncology · 62
Expression of Benign and Malignant Thyroid Tissue in Ovarian Teratomas and the Importance of Multimodal Management as Illustrated by a BRAF -Positive Follicular Variant of Papillary Thyroid Cancer
2010 · Erin F. Wolff, Marybeth Hughes, et al. · Thyroid · 58
Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma
2017 · Jeremy L. Davis, Russell C. Langan, et al. · Annals of Surgical Oncology · 51
Primary Gallbladder Neuroendocrine Tumors: Insights into a Rare Histology Using a Large National Database
2019 · Reed I. Ayabe, Michael Wach, et al. · Annals of Surgical Oncology · 50
Works count: 313
Citation count: 8,912
H-index: 35
I10-index: 87
Year
Topic
Type